Navigate this market better. Subscribe for FREE stock alerts and information.

Monday, October 3, 2011

Investment Firm Upgrades and Downgrades: (NEWP), (NWY), (IDA), (CRMD), (KIOR)

Newport (NEWP) recently had their rating decreased from Buy to Neutral. Longbow is the brokerage firm which is currently analyzing this company and found it necessary to change their rating. This is usually a bearish sign for the stock, and this brokerage house may tell its clients to sell the stock. The share prices may fall because of this action. Analysts believe that the company's share price may begin to fall. Shares of NEWP fell by 5.64% or $-0.61/share to $10.20. In the past year, the shares have traded as low as $10.50 and as high as $19.84. On average, 258666 shares of NEWP exchange hands on a given day and today's volume is recorded at 146831.

New York & Co (NWY) is currently being analyzed by the brokerage firm KeyBanc Capital Mkts. They have just decreased their rating from Buy to Hold. This indicates that the company may not be doing as well as investors were expecting. Look for potential selling pressure or a downside move in the share price. Shares of NWY traded higher by 0.31% or $0.01/share to $3.20. In the past year, the shares have traded as low as $2.48 and as high as $7.50. On average, 212963 shares of NWY exchange hands on a given day and today's volume is recorded at 27553.

KeyBanc Capital Mkts, the brokerage firm, has recently changed the rating on IdaCorp (IDA). They upped the rating from Hold to Buy. The brokerage firm believes the company may be on the upswing and there could be potential value in buying the stock. The target price is currently set at $41 per share by the brokerage firm. Shares of IDA traded higher by 1.69% or $0.64/share to $38.42. In the past year, the shares have traded as low as $33.88 and as high as $40.71. On average, 349966 shares of IDA exchange hands on a given day and today's volume is recorded at 157144.

Maxim Group, the brokerage firm, has recently decreased the rating on Cormedix (CRMD). They lowered the rating from Buy to Hold. The brokerage firm believes the company is on the downswing and there could be potential savings or capital preservation in selling the stock now. Shares of CRMD fell by 13.19% or $-0.12/share to $0.79. In the past year, the shares have traded as low as $0.82 and as high as $2.50. On average, 4317 shares of CRMD exchange hands on a given day and today's volume is recorded at 9349.

KiOR (KIOR) recently had their rating decreased from Neutral to Underperform. Robert W. Baird is the brokerage firm which is currently analyzing this company and found it necessary to change their rating. This is usually a bearish sign for the stock, and this brokerage house may tell its clients to sell the stock. The share prices may fall because of this action. Analysts believe that the company's share price may begin to fall. The target price is currently set at $13 per share by the brokerage firm. Shares of KIOR fell by 4.05% or $-0.84/share to $19.90. In the past year, the shares have traded as low as $8.88 and as high as $23.85. On average, 168068 shares of KIOR exchange hands on a given day and today's volume is recorded at 34966.